Alzheimer's Dementia
16
2
3
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.3%
1 terminated out of 16 trials
88.9%
+2.4% vs benchmark
25%
4 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (16)
Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression
Feasibility of Wearables in Dementia Care in Rural Taiwan
Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)
Electroacupuncture Treatment of Behavioral and Psycological Symptoms in Patients With Alzheimer's Disease
Electroacupuncture for the Treatment of Agitated Symptoms of Alzheimer's Disease
Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia
Electronic Consultation for AD/ADRD Residents Experiencing Infectious Diseases
Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)
European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)
Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)
Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
Effect of Virtual Reality on Balance and Gait Speed With Alzheimer's Dementia
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
Delta-THC in Dementia
Cilostazol Augmentation Study in Dementia
Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease